Diagnos Laboratorium Utama Tbk. vs Estee Gold Feet Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 22.7K 24h volume), while Estee Gold Feet Tbk. trades at Rp1,755 (market cap 4.42T, 20.1K 24h volume). The key difference: Estee Gold Feet Tbk. is far larger — about 14.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (22.7K versus 20.1K). Which is the better fit depends on your goals.
| DGNS | EURO | |
|---|---|---|
Market Cap | 308B | 4.42T |
Volume | 22.7K | 20.1K |
Lot | 227 | 201 |
Turnover | 5.17M | 35.06M |
Average Price | 227.59 | 1,744.15 |
Value | 5.17M | 35.06M |
Indicative Equilibrium Price | 230 | — |
Indicative Equilibrium Volume | 110 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Estee Gold Feet Tbk (Company) was established by Notarial Deed No. 32 dated January 21, 1980 from Abdoel Sjoekoer, S.H., Notary in Jakarta. The Company started its commercial operations in 1986. The Company is controlled by its immediate parent company, PT Timmsvale, a company domiciled in Indonesia. The ultimate beneficial owners of the Company are Johansen Ngian.
Read more on EURO →